Clinical Trials Browser

Phase 2 × NIH × Ferrosoferric Oxide × Clear all

NCT02141490 2019-09-06

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

Phase 2 Completed

43 enrolled 12 charts

Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms